Publication | Closed Access

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain

Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineNatural SciencesGrowth Factor-β TypeRational Drug DesignPharmacological AgentPharmacologyKinase DomainDrug Discovery